Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

Conditions

Breast Cancer

What is the purpose of this trial?

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using tamoxifen citrate may fight cancer by blocking the use of estrogen by tumor cells.

PURPOSE: This phase II trial is studying how well tamoxifen citrate works in patients with metastatic or recurrent breast cancer.



Participation Guidelines

Age:
18 Years - N/A
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Dates:
September 2010
Last Updated:
December 6, 2012
Study HIC#:

Clinicaltrials.gov ID: NCT01124695